Pediatric ICU and Trauma Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Institute of Anesthesia and Intensive Care, Catholic University of the Sacred Heart of Rome, Rome, Italy.
J Intensive Care Med. 2022 Feb;37(2):177-184. doi: 10.1177/0885066620983744. Epub 2021 Jan 19.
To determine whether non-invasive ventilation (NIV) can avoid the need for tracheal intubation and/or reduce the duration of invasive ventilation (IMV) in previously intubated patients admitted to the pediatric intensive care unit (PICU) and developing acute hypoxemic respiratory failure (AHRF) after major traumatic injury.
A single center observational cohort study.
Pediatric ICU in a University Hospital (tertiary referral Pediatric Trauma Centre).
During the 48-month study period, 276 patients (median age 6.4 years) with trauma were admitted to PICU; among 86 of them, who suffered from AHRF and received ventilation (IMV and/or NIV) for more than 12 hrs, 32 patients (median age 8.5 years) were treated with NIV.
INCLUSION/EXCLUSION CRITERIA: Inclusion criteria: at least 12 hours of NIV; exclusion criteria: patients with facial trauma or congenital malformations; patients receiving IMV <12 hours or perioperative ventilation.
Among NIV patients, 27 (84,3%) were previously on IMV, while 5 (15,6%) could be managed exclusively with NIV. In patients with post-extubation respiratory distress, NIV was successful in 88.4% of cases. Before starting NIV, P/F ratio was 242.7 ± 71. After 8 hours of NIV treatment, a significant oxygenation improvement (PaO2/FiO2 = 354.3 ± 81; p = 0.0002) was found, with no significant changes in carbon dioxide levels. A trend toward increasing ventilation-free time has been evidenced; NIV resulted feasible and generally well tolerated.
AHRF in trauma patients is multifactorial and may be due to many reasons, such as lung contusion, aspiration of blood or gastric contents. Systemic inflammatory response and transfusions may also contribute to hypoxia. Our pilot study strongly suggests that NIV can be applied in post-traumatic AHRF: it may successfully reduce the time of both invasive ventilation and deep sedation. Further data from controlled studies are needed to assess the advantage of NIV in pediatric trauma.
确定无创通气(NIV)是否可以避免气管插管的需要和/或减少先前插管的患者在重症监护病房(PICU)中因创伤后发生急性低氧性呼吸衰竭(AHRF)并接受侵入性通气(IMV)的时间。
单中心观察队列研究。
大学医院儿科重症监护病房(三级转诊儿科创伤中心)。
在 48 个月的研究期间,276 名(中位年龄 6.4 岁)创伤患者被收入 PICU;其中 86 名患者患有 AHRF 并接受了超过 12 小时的通气(IMV 和/或 NIV),32 名(中位年龄 8.5 岁)患者接受了 NIV 治疗。
纳入/排除标准:纳入标准:至少接受 12 小时的 NIV;排除标准:面部创伤或先天性畸形的患者;接受 IMV<12 小时或围手术期通气的患者。
在接受 NIV 的患者中,27 名(84.3%)患者之前接受过 IMV,而 5 名(15.6%)患者可以仅接受 NIV 治疗。在拔管后呼吸窘迫的患者中,NIV 成功率为 88.4%。在开始 NIV 之前,P/F 比为 242.7±71。在接受 8 小时的 NIV 治疗后,氧合明显改善(PaO2/FiO2=354.3±81;p=0.0002),二氧化碳水平无明显变化。已证明通气时间增加的趋势;NIV 可行且通常耐受良好。
创伤患者的 AHRF 是多因素的,可能是由于多种原因引起的,如肺挫伤、血液或胃内容物的吸入。全身炎症反应和输血也可能导致缺氧。我们的初步研究强烈表明,NIV 可应用于创伤后 AHRF:它可以成功减少侵入性通气和深度镇静的时间。需要来自对照研究的更多数据来评估 NIV 在儿科创伤中的优势。